Mathias Weiss serves as the Senior Strategic IP Manager at BIOTRONIK, where he plays a pivotal role in shaping and executing the intellectual property (IP) strategy for the Vascular Intervention (VI) business unit. With a robust background in lifesciences and patent law, Mathias is dedicated...
Mathias Weiss serves as the Senior Strategic IP Manager at BIOTRONIK, where he plays a pivotal role in shaping and executing the intellectual property (IP) strategy for the Vascular Intervention (VI) business unit. With a robust background in lifesciences and patent law, Mathias is dedicated to building and managing a business-driven IP portfolio that not only safeguards but also enhances the competitive advantage of BIOTRONIK's innovative products and technologies. His expertise encompasses a wide array of critical areas, including patentability assessments, patent prosecution, and licensing strategies, which are essential for navigating the complex landscape of medical device innovation.
In his current role, Mathias is actively involved in planning and conducting freedom to operate clearance activities, collaborating closely with patent attorneys to ensure that BIOTRONIK's advancements in vascular intervention are protected against potential infringements. He is also responsible for conducting thorough due diligence and patent portfolio analysis, which are vital for identifying opportunities for strategic partnerships and potential start-up collaborations. His keen insights into patent applications and prosecution processes enable him to effectively advocate for BIOTRONIK's interests in a highly competitive market.
Mathias's commitment to fostering innovation within the medical device sector is evident in his proactive approach to IP management. By aligning the IP strategy with the broader business objectives of BIOTRONIK, he ensures that the company remains at the forefront of technological advancements while mitigating risks associated with intellectual property. His strategic vision and comprehensive understanding of the intricacies of patent law position him as a key contributor to BIOTRONIK's ongoing success in the vascular intervention space.
